253 related articles for article (PubMed ID: 17585915)
21. Visual inspection with acetic acid and cytology as screening methods for cervical lesions in Cameroon.
Doh AS; Nkele NN; Achu P; Essimbi F; Essame O; Nkegoum B
Int J Gynaecol Obstet; 2005 May; 89(2):167-73. PubMed ID: 15847890
[TBL] [Abstract][Full Text] [Related]
22. Knowledge, attitudes and practices on cervical cancer screening among the medical workers of Mulago Hospital, Uganda.
Mutyaba T; Mmiro FA; Weiderpass E
BMC Med Educ; 2006 Mar; 6():13. PubMed ID: 16509979
[TBL] [Abstract][Full Text] [Related]
23. Physician recommendation for papanicolaou testing among U.S. women, 2000.
Coughlin SS; Breslau ES; Thompson T; Benard VB
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1143-8. PubMed ID: 15894664
[TBL] [Abstract][Full Text] [Related]
24. Factors affecting cervical screening among Turkish women.
Erbil N; Tezcan Y; Gür EN; Yildirim M; Aliş N
Asian Pac J Cancer Prev; 2010; 11(6):1641-4. PubMed ID: 21338210
[TBL] [Abstract][Full Text] [Related]
25. Effects of Cardiovascular Disease on Compliance with Cervical and Breast Cancer Screening Recommendations Among Adult Women.
Guo F; Hirth JM; Berenson AB
J Womens Health (Larchmt); 2015 Aug; 24(8):641-7. PubMed ID: 26263281
[TBL] [Abstract][Full Text] [Related]
26. Breast and cervical cancer screening utilization among Hispanic women living near the United States-Mexico border.
Nuño T; Castle PE; Harris R; Estrada A; García F;
J Womens Health (Larchmt); 2011 May; 20(5):685-93. PubMed ID: 21428792
[TBL] [Abstract][Full Text] [Related]
27. Federal Support for Family Planning Clinics Associated with Dramatic Gains in Cervical Cancer Screening.
Nikpay SS
Womens Health Issues; 2016; 26(2):176-82. PubMed ID: 26781749
[TBL] [Abstract][Full Text] [Related]
28. Recency of Pap testing and future testing plans among women aged 18-64: analysis of the 2007 Health Information National Trends Survey.
Ashok M; Berkowitz Z; Hawkins NA; Tangka F; Saraiya M
J Womens Health (Larchmt); 2012 Jul; 21(7):705-12. PubMed ID: 22480224
[TBL] [Abstract][Full Text] [Related]
29. Pap smear screening at an urban aboriginal health service: report of a practice audit and an evaluation of recruitment strategies.
Hunt JM; Gless GL; Straton JA
Aust N Z J Public Health; 1998 Oct; 22(6):720-5. PubMed ID: 9848971
[TBL] [Abstract][Full Text] [Related]
30. Improving adherence to regular pap smear screening among Asian women: a population-based study in Singapore.
Lee J; Seow A; Ling SL; Peng LH
Health Educ Behav; 2002 Apr; 29(2):207-18. PubMed ID: 11942715
[TBL] [Abstract][Full Text] [Related]
31. Use of laboratory reports to assess cervical cancer screening in a community.
Orr ST; Celentano DD; Hill G; Erozan YS; Shediac M; Correa-Villasenor A; Matanoski G
Am J Prev Med; 1994; 10(4):235-7. PubMed ID: 7803067
[TBL] [Abstract][Full Text] [Related]
32. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
33. Trends in abnormal cancer screening results in the United States of America.
Yabroff KR; Freedman A; Brown ML; Ballard-Barbash R; McNeel T; Taplin S
J Med Screen; 2007; 14(2):67-72. PubMed ID: 17626704
[TBL] [Abstract][Full Text] [Related]
34. Race and ethnic disparities in cervical cancer screening in a safety-net system.
Owusu GA; Eve SB; Cready CM; Koelln K; Trevino F; Urrutia-Rojas X; Baumer J
Matern Child Health J; 2005 Sep; 9(3):285-95. PubMed ID: 16163439
[TBL] [Abstract][Full Text] [Related]
35. Limited Pap screening associated with reduced risk of cervical cancer in South Africa.
Hoffman M; Cooper D; Carrara H; Rosenberg L; Kelly J; Stander I; Williamson AL; Denny L; du Toit G; Shapiro S
Int J Epidemiol; 2003 Aug; 32(4):573-7. PubMed ID: 12913031
[TBL] [Abstract][Full Text] [Related]
36. Papanicolaou testing among Native American and Hispanic populations.
Moreland S; Engelman K; Greiner KA; Mayo MS
Ethn Dis; 2006; 16(1):223-7. PubMed ID: 16599374
[TBL] [Abstract][Full Text] [Related]
37. Papanicolaou smear: can we make a good test better? Technical and interpretive challenges for the practitioner.
Eltabbakh GH; Eltabbakh GD
J Womens Health Gend Based Med; 1999 May; 8(4):469-76. PubMed ID: 10839701
[TBL] [Abstract][Full Text] [Related]
38. Pap screening in a U.S. health plan.
Insinga RP; Glass AG; Rush BB
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):355-60. PubMed ID: 15006908
[TBL] [Abstract][Full Text] [Related]
39. Papanicolaou smear screening of women with intellectual disabilities: a cross-sectional survey in Taiwan.
Lin LP; Lin JD; Sung CL; Liu TW; Liu YL; Chen LM; Chu CM
Res Dev Disabil; 2010; 31(2):403-9. PubMed ID: 19897337
[TBL] [Abstract][Full Text] [Related]
40. Pap smear use in a population of older Mexican-American women.
Randolph WM; Freeman DH; Freeman JL
Women Health; 2002; 36(1):21-31. PubMed ID: 12215001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
